Search Results for keywords:"Strategic National Stockpile"

The executive order aims to strengthen the United States' response to the COVID-19 pandemic by ensuring a robust supply chain for necessary medical supplies. It directs several federal departments to assess and address shortages in pandemic response supplies like PPE and vaccines and suggests using the Defense Production Act to resolve these shortfalls. The order also focuses on strategies for long-term resilience in the pandemic supply chain, pricing controls to prevent hoarding and price gouging, and better access to the Strategic National Stockpile for Tribal authorities. Additionally, it requires a plan for enhancing domestic manufacturing capabilities for future pandemics.

The Food and Drug Administration (FDA) is seeking public feedback on a proposed information collection regarding prescription drug labeling. This information is being reviewed by the Office of Management and Budget (OMB) as required by the Paperwork Reduction Act. The proposal primarily concerns updating and revising regulations for drug labeling, including safety labeling changes and medical gas container labeling. The FDA is inviting comments until March 5, 2025, and offers guidance for companies required to comply with these labeling standards.